Changes in planned disease management after piflufolastat F18 PET/CT in men with biochemically recurrent prostate cancer and low PSA levels: A secondary analysis of results from the CONDOR study.
用户P-mPQbgVJoNg
1个月前
74
10
已完结
1. 系统已在2026-04-09 15:51:09对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/JCO.2023.41.6_suppl.61
文献链接: https://ascopubs.org/doi/10.1200/JCO.2023.41.6_suppl.61
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Frederic Pouliot; Michael A. Gorin; Steven P. Rowe; Lawrence Saperstein; Bela Stephen Denes; Vincent A. DiPippo; Nancy Stambler; Michael J. Morris; Barry A. Siegel
